Trials / Completed
CompletedNCT04172818
Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Allogenic hematopoietic stem cell transplantation is a specific time during hematological disease management for the patients, theirs relatives and the healthcare team. This heavy treatment is most of the time the last possible curative therapy and could cause many side effects such as infectious diseases and graft versus host reaction. The protective isolation is also a source of physical and psychological isolation. Published studies reported depressive syndrome, anxiety symptoms and post-traumatic stress disorders for patients and their families. Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma. In analogy, the diary for the patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long terms consequences. The investigators want to evaluate the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | quality of life questionnaire | Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma.In analogy, the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences. The psychological impact of a diary on patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives will be evaluated. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-05-01
- Completion
- 2023-03-21
- First posted
- 2019-11-21
- Last updated
- 2023-03-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04172818. Inclusion in this directory is not an endorsement.